{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:23:01Z","timestamp":1787844181451,"version":"build-2784847793"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:p>Oral dapsone is effective in treating several dermatologic conditions, including acne vulgaris. However, the rate of adverse effects of oral dapsone is a concern when prescribing it. Topical dapsone may mitigate these adverse effects and enhance the safety and tolerability of dapsone. Here, we review the published reports and studies to examine the efficacy and safety of topical dapsone in treating acne. A literature review was conducted using the PubMed database. The review considered patient and disease factors, such as the type of acne, acne location, patient gender, age, skin type, and race. Other factors, such as the duration and dosage of treatment, monotherapy versus combination therapy, adverse events, and safety profiles, were also compared. Topical dapsone was well tolerated and effective across a variety of acne presentations and patient subgroups. It showed a favorable safety profile, even in patients with comorbidities, such as G6PD deficiency. We conclude that topical dapsone is safe, effective, and well tolerated in the treatment of acne, contrary to its oral form.<\/jats:p>","DOI":"10.4103\/jfmpc.jfmpc_256_25","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T10:00:22Z","timestamp":1770372022000},"page":"33-38","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Safety and effectiveness of topical dapsone in acne treatment: A review"],"prefix":"10.4103","volume":"15","author":[{"given":"Sami N.","family":"Alsuwaidan","sequence":"first","affiliation":[{"name":"Department of Dermatology, College of Medicine, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tala A.","family":"Qadoumi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, College of Medicine, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,2,7]]},"reference":[{"key":"R1-20260206","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1517\/14656560903002097","article-title":"An evaluation of dapsone gel 5% in the treatment of acne vulgaris","volume":"10","author":"Pickert","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"R2-20260206","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1111\/jocd.14011","article-title":"Dapsone for acne: Still in use after half a century!","volume":"20","author":"Searle","year":"2021","journal-title":"J Cosmet Dermatol"},{"key":"R4-20260206","doi-asserted-by":"crossref","first-page":"611","DOI":"10.21037\/apm-21-3935","article-title":"Efficacy and safety of dapsone gel for acne: A systematic review and meta-analysis","volume":"11","author":"Wang","year":"2022","journal-title":"Ann Palliat Med"},{"key":"R5-20260206","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1111\/ijd.16074","article-title":"Topical dapsone in the treatment of acne: A systematic review","volume":"61","author":"Nickles","year":"2022","journal-title":"Int J Dermatol"},{"key":"R6-20260206","doi-asserted-by":"crossref","first-page":"101578","DOI":"10.1016\/j.bbrep.2023.101578","article-title":"Acne vulgaris: A review of the pathophysiology, treatment, and recent nanotechnology based advances","volume":"36","author":"Vasam","year":"2023","journal-title":"Biochemistry and Biophysics Reports"},{"key":"R7-20260206","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijwd.2017.10.006","article-title":"A review of diagnosis and treatment of acne in adult female patients","volume":"4","author":"Tan","year":"2018","journal-title":"Int J Women's Dermatol"},{"key":"R8-20260206","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.clindermatol.2016.10.010","article-title":"Topical treatments for acne","volume":"35","author":"Kosmadaki","year":"2017","journal-title":"Clin Dermatol"},{"key":"R10-20260206","first-page":"AB7","volume":"74","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"R11-20260206","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1208\/s12249-023-02564-1","article-title":"Dapsone-loaded mixed micellar gel for treatment OF acne vulgaris","volume":"24","author":"Rao","year":"2023","journal-title":"AAPS PharmSciTech"},{"key":"R13-20260206","doi-asserted-by":"crossref","first-page":"P20","DOI":"10.1016\/j.jaad.2004.10.094","article-title":"Pharmacokinetics of 5% dapsone topical gel demonstrates minimal systemic exposure","volume":"52","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R14-20260206","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2165\/00003088-200746080-00006","article-title":"Pharmacokinetics of dapsone gel, 5% for the treatment of acne vulgaris","volume":"46","author":"Thiboutot","year":"2007","journal-title":"Clin Pharm"},{"key":"R15-20260206","first-page":"1250","article-title":"Safety and pharmacokinetics of once-daily dapsone gel, 7.5% in patients with moderate acne vulgaris","volume":"15","author":"Jarratt","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"R16-20260206","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2165\/00128071-200910040-00002","article-title":"Dapsone 5% Gel","volume":"10","author":"Stotland","year":"2009","journal-title":"Am J Clin Dermatol"},{"key":"R17-20260206","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/pde.14080","article-title":"Severe methemoglobinemia due to topical dapsone misuse in a teenage girl","volume":"37","author":"Yale","year":"2020","journal-title":"Pediatr Dermatol"},{"key":"R18-20260206","first-page":"e28811","article-title":"Refractory methemoglobinemia secondary to topical dapsone with subsequent autoimmune hemolytic anemia","volume":"14","author":"Cantrell","year":"2022","journal-title":"Cureus"},{"key":"R19-20260206","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s40257-016-0242-0","article-title":"Dapsone 7.5% gel: A review in acne vulgaris","volume":"18","author":"Al-Salama","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"R20-20260206","first-page":"602","article-title":"Clinical experience with once-daily dapsone gel, 7.5% monotherapy in patients with acne vulgaris","volume":"17","author":"Stockton","year":"2018","journal-title":"J Drugs Dermatol"},{"key":"R21-20260206","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s40257-024-00879-8","article-title":"Dapsone use in dermatology","volume":"25","author":"Lovell","year":"2024","journal-title":"Am J Clin Dermatol"},{"key":"R22-20260206","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1001\/archdermatol.2009.186","article-title":"Interaction of topical sulfacetamide and topical dapsone with benzoyl peroxide","volume":"145","author":"Dubina","year":"2009","journal-title":"Arch Dermatol"},{"key":"R23-20260206","doi-asserted-by":"crossref","first-page":"439.e1","DOI":"10.1016\/j.jaad.2006.10.005","article-title":"Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris","volume":"56","author":"Draelos","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"R24-20260206","first-page":"138","article-title":"Case report of methemoglobinemia in a toddler secondary to topical dapsone exposure","author":"Graff","year":"2016","journal-title":"BMC Pediatr"},{"key":"R25-20260206","doi-asserted-by":"crossref","first-page":"3092910","DOI":"10.1155\/2024\/3092910","article-title":"Efficacy and safety of topical dapsone for acne vulgaris: A systemic review with meta-analysis","author":"Treetanuchai","year":"2024","journal-title":"Dermatol Ther 2024"},{"key":"R26-20260206","first-page":"981","article-title":"Dapsone gel long-term safety study group dapsone gel 5% for the treatment of acne vulgaris: Safety and efficacy of long-term (1 year) treatment","volume":"6","author":"Lucky","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"R27-20260206","first-page":"45","article-title":"Management of truncal acne vulgaris with topical dapsone 7.5% gel","volume":"11","author":"Del Rosso","year":"2018","journal-title":"J Clin Aesthet Dermatol"},{"key":"R28-20260206","first-page":"33","article-title":"Dapsone gel in combination treatment study group dapsone gel 5% in combination with adapalene gel 0.1%, benzoyl peroxide gel 4% or moisturizer for the treatment of acne vulgaris: A 12-week, randomized, double-blind study","volume":"9","author":"Fleischer","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"R29-20260206","first-page":"783","article-title":"Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: Findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgaris","volume":"10","author":"Tanghetti","year":"2011","journal-title":"J Drugs Dermatol"},{"key":"R30-20260206","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4103\/2277-9175.139413","article-title":"The efficacy of 5% dapsone gel plus oral isotretinoin versus oral isotretinoin alone in acne vulgaris: A randomized double-blind study","volume":"3","author":"Faghihi","year":"2014","journal-title":"Adv Biomed Res"},{"key":"R31-20260206","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1001\/archdermatol.2008.518","article-title":"Hematologic safety of dapsone gel, 5%, for topical treatment of acne vulgaris","volume":"144","author":"Piette","year":"2008","journal-title":"Arch Dermatol"},{"key":"R32-20260206","first-page":"532","article-title":"Is topical dapsone safe in glucose-6-phosphate dehydrogenase-deficient and sulfonamide-allergic patients?","volume":"9","author":"Webster","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"R33-20260206","first-page":"779","article-title":"Treatment of acne vulgaris during pregnancy and lactation","volume":"73","author":"Kong","year":"2013","journal-title":"Nordisk Alkohol Nark"},{"key":"R34-20260206","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s13555-022-00854-3","article-title":"Treatment of acne vulgaris during pregnancy and lactation: A narrative review","volume":"13","author":"Ly","year":"2023","journal-title":"Dermatol Ther"},{"key":"R35-20260206","doi-asserted-by":"crossref","first-page":"e2024034","DOI":"10.5826\/dpc.1401a34","article-title":"Efficacy of topical dapsone 5% gel for the treatment of erythematotelangiectatic rosacea: New treatment option with old drug","volume":"14","author":"G\u00f6k\u015fin","year":"2024","journal-title":"Dermatol Pract Concept"},{"key":"R36-20260206","first-page":"602","article-title":"Dapsone gel in the treatment of papulopustular rosacea: A double-blind randomized clinical trial","volume":"14","author":"Faghihi","year":"2015","journal-title":"J Drugs Dermatol"},{"key":"R37-20260206","first-page":"160","article-title":"Efficacy, safety, and tolerability of topical dapsone gel, 7.5% for treatment of acne vulgaris by fitzpatrick skin phototype","volume":"17","author":"Taylor","year":"2018","journal-title":"J Drugs Dermatol"},{"key":"R38-20260206","first-page":"197","article-title":"The efficacy and safety of topical dapsone gel, 5% for the treatment of acne vulgaris in adult females with skin of color","volume":"15","author":"Alexis","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"R39-20260206","first-page":"1192","article-title":"Once-daily topical dapsone gel, 7.5%: Effective for acne vulgaris regardless of baseline lesion count, with superior efficacy in females","volume":"17","author":"Tanghetti","year":"2018","journal-title":"J Drugs Dermatol"},{"key":"R40-20260206","first-page":"1417","article-title":"The efficacy and tolerability of dapsone 5% gel in female vs male patients with facial acne vulgaris: Gender as a clinically relevant outcome variable","volume":"11","author":"Tanghetti","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"R41-20260206","first-page":"31","article-title":"Comparative efficacy and tolerability of dapsone 5% gel in adult versus adolescent females with acne vulgaris","volume":"8","author":"Del Rosso","year":"2015","journal-title":"J Clin Aesth Dermatol"},{"key":"R42-20260206","first-page":"43","article-title":"Once-daily Dapsone 7.5% gel for the treatment of acne vulgaris in preadolescent patients: A phase IV, open-label, 12-week study","volume":"14","author":"Moore","year":"2021","journal-title":"J Clin Aesthet Dermatol"},{"key":"R43-20260206","first-page":"591","article-title":"Treatment response with once-daily topical dapsone gel, 7.5% for acne vulgaris: Subgroup analysis of pooled data from two randomized, double-blind stu","volume":"16","author":"Draelos","year":"2017","journal-title":"J Drugs Dermatol"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_256_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:12:57Z","timestamp":1787843577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_256_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_256_25","relation":{},"ISSN":["2249-4863","2278-7135"],"issn-type":[{"value":"2249-4863","type":"print"},{"value":"2278-7135","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2025-02-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}